0 Wrt signaling pathway(8 'r.) ¥ Cadherin signaling pathway(6'r.) 0 C'\f:o9<eletal regulation by Rho GTPasÛ(4'r.) 0 Heterotrimeric G-protein signaling pathwa~Gi alpha and Q; alpha medated pathway(4%) ¥ ~zheimerdisease-p-esenlin pathway(4'r.) c ~cotinic acetylcholine receptor signaling p.thway (4'r.) ¥ En:lothel n signaling pathway(4'r.) 0 hflammation mediated bychemol<ine and cytokine signaling pathway( 4%) ¥ Lbiquitin ~eaS~Jme pathway(4'r.) ¥ hstlin/IGF pathwa~protein l<inase 9 signaling cascade (4'r.) 0 ~ptosissignaling pathway(2'r.) c Po;jiogenesis (2'r.) ¥ 0-antigen biosyrthesis (2 'r.) ¥ Metabotropic glutamate rece~orgroup I pathway (2 'fl) ¥ Metabotropic glutamate rece~orgroup II p.thway(2 rr.; ¥ ParkinS~Jn disease (2'fl) c Glycolysis (2'fl) 0 Metabotropic glutamate receptorgroup Ill pathwa\(2'fl) 0 ~dgehog signaling pathway(2'fl) c hstlin/IGF pathwa~mitogen actiwte:l protein kinase kinase/MAP k nase cascade(2 'fl) 0 Transcri~ionregulation bybZIP transcripti on factor(2'fl) 0 p53 pathway taedback loops 2 (2rr.) c p53 pathway(2'fl) 0 :5HT1 ~receptormediated signaling pathway(2'fl) ¥ Beta 1 adrenergc receptor signaling pathway (2 'fl) c 9Eta2 adrenergc receptor signaling pathway (2 'fl) 0 H!tamne H2 receptormediated signaling pathwa\(2'fl) 0 GPCIAB rece~or llsignalin;l (2 'fl) c p38 MAPKpathJJ ay(2 rr.) [] p53 pathway byglucose deJ:rivation (2'fl) ¥ Dopamne rece~orme:liated signaling pathway(2'fl) c Others (S'fl) 